AN2 Therapeutics Inc (ANTX)
1.99
-0.05
(-2.45%)
USD |
NASDAQ |
May 31, 16:00
2.02
+0.03
(+1.51%)
After-Hours: 20:00
AN2 Therapeutics Market Cap: 59.36M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 59.36M |
| May 30, 2024 | 60.85M |
| May 29, 2024 | 62.34M |
| May 28, 2024 | 63.24M |
| May 24, 2024 | 60.25M |
| May 23, 2024 | 59.96M |
| May 22, 2024 | 63.24M |
| May 21, 2024 | 64.58M |
| May 20, 2024 | 66.52M |
| May 17, 2024 | 67.71M |
| May 16, 2024 | 67.71M |
| May 15, 2024 | 67.71M |
| May 14, 2024 | 68.90M |
| May 13, 2024 | 70.10M |
| May 10, 2024 | 72.19M |
| May 09, 2024 | 73.68M |
| May 08, 2024 | 72.78M |
| May 07, 2024 | 76.06M |
| May 06, 2024 | 77.26M |
| May 03, 2024 | 76.36M |
| May 02, 2024 | 75.77M |
| May 01, 2024 | 71.59M |
| April 30, 2024 | 71.59M |
| April 29, 2024 | 70.69M |
| April 26, 2024 | 69.20M |
| Date | Value |
|---|---|
| April 25, 2024 | 68.01M |
| April 24, 2024 | 71.59M |
| April 23, 2024 | 70.69M |
| April 22, 2024 | 70.37M |
| April 19, 2024 | 73.64M |
| April 18, 2024 | 70.96M |
| April 17, 2024 | 73.94M |
| April 16, 2024 | 73.64M |
| April 15, 2024 | 74.54M |
| April 12, 2024 | 81.70M |
| April 11, 2024 | 89.45M |
| April 10, 2024 | 90.64M |
| April 09, 2024 | 90.94M |
| April 08, 2024 | 89.75M |
| April 05, 2024 | 89.75M |
| April 04, 2024 | 96.90M |
| April 03, 2024 | 100.48M |
| April 02, 2024 | 101.37M |
| April 01, 2024 | 112.11M |
| March 28, 2024 | 96.75M |
| March 27, 2024 | 95.86M |
| March 26, 2024 | 92.88M |
| March 25, 2024 | 95.56M |
| March 22, 2024 | 99.14M |
| March 21, 2024 | 98.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
59.36M
Minimum
May 31 2024
640.33M
Maximum
Jan 09 2024
261.29M
Average
200.04M
Median
Mar 03 2023
Market Cap Benchmarks
| Revance Therapeutics Inc | 295.59M |
| Viking Therapeutics Inc | 6.870B |
| VYNE Therapeutics Inc | 37.05M |
| Aquestive Therapeutics Inc | 264.01M |
| Humacyte Inc | 889.56M |
Market Cap Related Metrics
| Price to Book Value | 0.5367 |
| Price | 1.99 |
| Earnings Yield | -130.2% |